Academy Sites Books Clinical CME E-mail Journals Links Medline Parents Pharmaceuticals Professional Research Teaching Web Portals Internet Course
Principal Investigator: David Neville, MD and Susan Swedo, MD
The purpose of this study is to see if the administration of minocycline will be helpful to children with regressive autism (autism with a history of loss of social and/or language skills). Minocycline is an antibiotic and will be taken orally in this study. It is FDA-approved for the treatment of a variety of infections and has been shown to improve brain inflammation in at least one neurological disorder. Minocycline’s anti-inflammatory properties may be beneficial in autism and may improve autistic symptoms.
Carrie Masur, Research Assistant
Go back to Seeking Patients page
Last revised 07-Feb-2007 by Steven Leber